VRTX Stock: Price, Earnings History and SEC Filings
Vertex Pharmaceuticals Incorporated (VRTX) last traded at $558.88, up 3.50% on the latest session and up 6.9% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $4.20 against an analyst estimate of $4.15, a beat of 1.2%.
$558.88 +3.50%
1 month+6.90%
52-week high$563.80
52-week low$403.16
Volume3.03M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
VRTX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 3, 2026 | $4.20 | $4.15 | +1.20% |
| Mar 2026 | May 4, 2026 | $3.95 | $3.69 | +7.05% |
| Dec 2025 | Feb 12, 2026 | $4.65 | $4.40 | +5.68% |
| Sep 2025 | Nov 3, 2025 | $4.22 | $4.00 | +5.50% |
VRTX beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for VRTX
SEC filing data is not available right now. You can search for VRTX on SEC EDGAR.
VRTX news
- Vertex Pharmaceuticals (VRTX) Stock May Still Have Value Following A 190% RunNov 1, 2026 · finance.yahoo.com
- Is Vertex Pharmaceuticals (VRTX) Fully Priced Following Its Kidney Data Update?Oct 31, 2026 · finance.yahoo.com
- What Just Happened To Alnylam Stock?Oct 30, 2026 · trefis.com
- 3 large-cap stocks with solid fundamentalsOct 30, 2026 · finance.yahoo.com
- Is 50% Crash Risk For Iovance Stock Real?Oct 30, 2026 · trefis.com
- Why Did Insmed Stock Jump?Oct 30, 2026 · trefis.com
- Can Iovance Stock Fall 50%?Oct 29, 2026 · trefis.com
- Biogen Crushes Earnings Estimates. As Old Blockbusters Fade, New Bets Pick Up the Slack.Oct 28, 2026 · finance.yahoo.com
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated (VRTX) is a US-listed public company on Nasdaq.